⌘K
Loading ticker…
Kura Oncology, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Kura Oncology, Inc. (KURA) has a 3-month relative strength percentile of 81 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.8%, relative volume 2.99×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 81, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
KURA is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $22M notional. Top 3 carry $59M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $22M |
| XBIState Street SPDR S&P Biotech ETF | 0.28% | $21M |
| IWMiShares Russell 2000 ETF | 0.02% | $16M |
| VXFVanguard Extended Market ETF | 0.01% | $8M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KURA Jan avg: 5.10% median: 1.09% win: 50% σ: 27.03% n: 4 2022-04-12 → 2026-05-29 | KURA Feb avg: -1.02% median: 1.07% win: 50% σ: 9.48% n: 4 2022-04-12 → 2026-05-29 | KURA Mar avg: -4.37% median: -2.84% win: 50% σ: 7.88% n: 4 2022-04-12 → 2026-05-29 | KURA Apr avg: -5.50% median: -7.12% win: 20% σ: 10.64% n: 5 2022-04-12 → 2026-05-29 | KURA May avg: 7.15% median: 5.05% win: 60% σ: 20.04% n: 5 2022-04-12 → 2026-05-29 | KURA Jun avg: 5.01% median: 0.65% win: 50% σ: 24.95% n: 4 2022-04-12 → 2026-05-29 (current) | KURA Jul avg: -2.97% median: -0.13% win: 50% σ: 9.36% n: 4 2022-04-12 → 2026-05-29 | KURA Aug avg: 4.36% median: -1.84% win: 50% σ: 18.02% n: 4 2022-04-12 → 2026-05-29 | KURA Sep avg: -1.20% median: -4.33% win: 25% σ: 9.30% n: 4 2022-04-12 → 2026-05-29 | KURA Oct avg: 1.97% median: 3.14% win: 50% σ: 15.16% n: 4 2022-04-12 → 2026-05-29 | KURA Nov avg: 0.07% median: 8.02% win: 75% σ: 23.78% n: 4 2022-04-12 → 2026-05-29 | KURA Dec avg: -2.03% median: -17.76% win: 25% σ: 33.98% n: 4 2022-04-12 → 2026-05-29 |